A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
This study has been completed.
Information provided by (Responsible Party):
National Institute of Mental Health (NIMH)
First received: January 17, 2000
Last updated: February 26, 2015
Last verified: April 2002
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Estimated Study Completion Date:||No date given|
|Primary Completion Date:||January 1990 (Final data collection date for primary outcome measure)|